Board of Scientific Counselors, National Center for Environmental Health/Agency for Toxic Substances and Disease Registry (BSC, NCEH/ATSDR), 17665 [2018-08367]
Download as PDF
<![CDATA[
Federal Register / Vol. 83, No. 78 / Monday, April 23, 2018 / Notices
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2018–08383 Filed 4–20–18; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Environmental
Health/Agency for Toxic Substances
and Disease Registry (BSC, NCEH/
ATSDR)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Board of Scientific Counselors,
National Center for Environmental
Health/Agency for Toxic Substances
and Disease Registry (BSC, NCEH/
ATSDR). This meeting is open to the
public, limited only by available
seating. The meeting room
accommodates approximately 60
people. The public is also welcome to
listen to the meeting by calling 888–
989–4501, passcode 9885805, limited by
100 lines. The deadline for notification
of attendance is May 14, 2018. The
public comment period is scheduled on
June 5, 2018 from 2:30 p.m. until 2:45
p.m., EDT and June 6, 2018 from 10:10
a.m. until 10:25 a.m., EDT. Individuals
wishing to make a comment during
Public Comment period, please email
your name, organization, and phone
number by May 7, 2018 to Amanda
Malasky at amalasky@cdc.gov.
DATES: The meeting will be held on June
5, 2018, 8:30 a.m. to 4:00 p.m., EDT and
June 6, 2018, 8:30 a.m. to 11:30 a.m.,
EDT.
ADDRESSES: CDC, 4770 Buford Highway,
CDC Building 106, Room 1B, Atlanta,
GA 30341.
FOR FURTHER INFORMATION CONTACT:
Shirley Little, Program Analyst, NCEH/
ATSDR, CDC, 4770 Buford Hwy., Mail
Stop F–45, Atlanta, GA 30341,
telephone (770) 488–0577; email snl7@
cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Secretary, Department
of Health and Human Services (HHS)
and by delegation, the Director, CDC
amozie on DSK30RV082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:09 Apr 20, 2018
Jkt 244001
and Administrator, NCEH/ATSDR, are
authorized under Section 301 (42 U.S.C.
241) and Section 311 (42 U.S.C. 243) of
the Public Health Service Act, as
amended, to: (1) Conduct, encourage,
cooperate with, and assist other
appropriate public authorities, scientific
institutions, and scientists in the
conduct of research, investigations,
experiments, demonstrations, and
studies relating to the causes, diagnosis,
treatment, control, and prevention of
physical and mental diseases and other
impairments; (2) assist states and their
political subdivisions in the prevention
of infectious diseases and other
preventable conditions and in the
promotion of health and wellbeing; and
(3) train state and local personnel in
health work. The BSC, NCEH/ATSDR
provides advice and guidance to the
Secretary, HHS; the Director, CDC and
Administrator, ATSDR; and the
Director, NCEH/ATSDR, regarding
program goals, objectives, strategies, and
priorities in fulfillment of the agency’s
mission to protect and promote people’s
health. The board provides advice and
guidance that will assist NCEH/ATSDR
in ensuring scientific quality,
timeliness, utility, and dissemination of
results. The board also provides
guidance to help NCEH/ATSDR work
more efficiently and effectively with its
various constituents and to fulfill its
mission in protecting America’s health.
Matters to be Considered: The agenda
will include discussions on Recovery
Efforts to Address Environmental Health
Impacts after the 2017 Hurricanes,
NCEH/ATSDR Program Responses to
BSC Guidance and Action Items, PFAS
multi-site study, PEASE, Biomonitoring
for PFAS in children, Use of Citizen
Science for Assessment of Health Risks,
Statistical Inferences in Environmental
Epidemiology, and NCEH/ASTDR work
with tribes/Tribal Programs. Agenda
items are subject to change as priorities
dictate.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elizabeth Millington,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2018–08367 Filed 4–20–18; 8:45 am]
BILLING CODE 4163–19–P
PO 00000
Frm 00024
Fmt 4703
Sfmt 4703
17665
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2018–N–1242]
Advisory Committee; Arthritis
Advisory Committee, Renewal
AGENCY:
Food and Drug Administration,
HHS.
Notice; renewal of advisory
committee.
ACTION:
The Food and Drug
Administration (FDA) is announcing the
renewal of the Arthritis Advisory
Committee by the Commissioner of
Food and Drugs (the Commissioner).
The Commissioner has determined that
it is in the public interest to renew the
Arthritis Advisory Committee for an
additional 2 years beyond the charter
expiration date. The new charter will be
in effect until April 5, 2020.
DATES: Authority for the Arthritis
Advisory Committee will expire on
April 5, 2020, unless the Commissioner
formally determines that renewal is in
the public interest.
FOR FURTHER INFORMATION CONTACT:
Yinghua Wang, Center for Drug
Evaluation and Research, Food and
Drug Administration, 10903 New
Hampshire Ave., Bldg. 31, Rm. 2417,
Silver Spring, MD 20993–0002, 301–
796–9001, email: AAC@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Pursuant
to 41 CFR 102–3.65 and approval by the
Department of Health and Human
Services pursuant to 45 CFR part 11 and
by the General Services Administration,
FDA is announcing the renewal of the
Arthritis Advisory Committee (the
Committee). The Committee is a
discretionary Federal advisory
committee established to provide advice
to the Commissioner.
The Committee advises the
Commissioner or designee in
discharging responsibilities as they
relate to helping to ensure safe and
effective drugs for human use and, as
required, any other product for which
FDA has regulatory responsibility.
The Committee reviews and evaluates
data concerning the safety and
effectiveness of marketed and
investigational human drug products for
use in the treatment of arthritis,
rheumatism, and related diseases, and
makes appropriate recommendations to
the Commissioner.
The Committee shall consist of a core
of 11 voting members including the
Chair. Members and the Chair are
selected by the Commissioner or
designee from among authorities
SUMMARY:
E:\FR\FM\23APN1.SGM
23APN1
]]>Agencies
[Federal Register Volume 83, Number 78 (Monday, April 23, 2018)]
[Notices]
[Page 17665]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-08367]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Board of Scientific Counselors, National Center for Environmental
Health/Agency for Toxic Substances and Disease Registry (BSC, NCEH/
ATSDR)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Board of Scientific Counselors,
National Center for Environmental Health/Agency for Toxic Substances
and Disease Registry (BSC, NCEH/ATSDR). This meeting is open to the
public, limited only by available seating. The meeting room
accommodates approximately 60 people. The public is also welcome to
listen to the meeting by calling 888-989-4501, passcode 9885805,
limited by 100 lines. The deadline for notification of attendance is
May 14, 2018. The public comment period is scheduled on June 5, 2018
from 2:30 p.m. until 2:45 p.m., EDT and June 6, 2018 from 10:10 a.m.
until 10:25 a.m., EDT. Individuals wishing to make a comment during
Public Comment period, please email your name, organization, and phone
number by May 7, 2018 to Amanda Malasky at [email protected].
DATES: The meeting will be held on June 5, 2018, 8:30 a.m. to 4:00
p.m., EDT and June 6, 2018, 8:30 a.m. to 11:30 a.m., EDT.
ADDRESSES: CDC, 4770 Buford Highway, CDC Building 106, Room 1B,
Atlanta, GA 30341.
FOR FURTHER INFORMATION CONTACT: Shirley Little, Program Analyst, NCEH/
ATSDR, CDC, 4770 Buford Hwy., Mail Stop F-45, Atlanta, GA 30341,
telephone (770) 488-0577; email [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Secretary, Department of Health and Human Services
(HHS) and by delegation, the Director, CDC and Administrator, NCEH/
ATSDR, are authorized under Section 301 (42 U.S.C. 241) and Section 311
(42 U.S.C. 243) of the Public Health Service Act, as amended, to: (1)
Conduct, encourage, cooperate with, and assist other appropriate public
authorities, scientific institutions, and scientists in the conduct of
research, investigations, experiments, demonstrations, and studies
relating to the causes, diagnosis, treatment, control, and prevention
of physical and mental diseases and other impairments; (2) assist
states and their political subdivisions in the prevention of infectious
diseases and other preventable conditions and in the promotion of
health and wellbeing; and (3) train state and local personnel in health
work. The BSC, NCEH/ATSDR provides advice and guidance to the
Secretary, HHS; the Director, CDC and Administrator, ATSDR; and the
Director, NCEH/ATSDR, regarding program goals, objectives, strategies,
and priorities in fulfillment of the agency's mission to protect and
promote people's health. The board provides advice and guidance that
will assist NCEH/ATSDR in ensuring scientific quality, timeliness,
utility, and dissemination of results. The board also provides guidance
to help NCEH/ATSDR work more efficiently and effectively with its
various constituents and to fulfill its mission in protecting America's
health.
Matters to be Considered: The agenda will include discussions on
Recovery Efforts to Address Environmental Health Impacts after the 2017
Hurricanes, NCEH/ATSDR Program Responses to BSC Guidance and Action
Items, PFAS multi-site study, PEASE, Biomonitoring for PFAS in
children, Use of Citizen Science for Assessment of Health Risks,
Statistical Inferences in Environmental Epidemiology, and NCEH/ASTDR
work with tribes/Tribal Programs. Agenda items are subject to change as
priorities dictate.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elizabeth Millington,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2018-08367 Filed 4-20-18; 8:45 am]
BILLING CODE 4163-19-P
